Stay updated on Immunotherapy with Chemo in HER2-neg IBC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with Chemo in HER2-neg IBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with Chemo in HER2-neg IBC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s displayed software/version revision label was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:41:17.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:56:12.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    - Added a new reference term 'Inflammatory breast carcinoma' and a Resources entry for the Genetic and Rare Diseases Information Center. - Added iRECIST guideline citation (Lancet Oncol. 2017) to the study references and removed the corresponding Erratum (Lancet Oncol. 2019).
    Difference
    0.2%
    Check dated 2026-04-02T15:47:54.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T07:42:05.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T04:44:44.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Addition and deletion of the same iRECIST reference cancel each other out, resulting in no net change to the page content. The study's design and outcome information remain unchanged.
    Difference
    0.0%
    Check dated 2026-03-05T02:17:39.000Z thumbnail image

Stay in the know with updates to Immunotherapy with Chemo in HER2-neg IBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with Chemo in HER2-neg IBC Clinical Trial page.